01 1DAITO CORP
01 1AZELASTINE HYDROCHLORIDE DAITO USP
01 1Japan
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-10
Pay. Date : 2013-08-29
DMF Number : 18398
Submission : 2005-06-01
Status : Active
Type : II
20
Daito Pharmaceutical Co Ltd, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is AZELASTINE HYDROCHLORIDE DAITO USP, with a corresponding US DMF Number 18398.
Remarkably, this DMF maintains an Active status since its submission on June 01, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 10, 2013, and payment made on August 29, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
